JBH:ASXJB Hi-Fi Limited Analysis
Data as of 2026-03-11 - not real-time
A$78.71
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
JB Hi‑Fi is trading at AU$78.71, which sits below its 20‑day SMA of 81.54 and 50‑day SMA of 85.23, indicating short‑term weakness. The RSI is around 41, suggesting the stock is not yet oversold, while the MACD histogram remains negative, confirming bearish momentum. Price is above the identified support at AU$72.26 but well under the resistance of AU$90.13, and the 30‑day volatility of over 40% points to sizable price swings. Despite the technical softness, the DCF fair‑value estimate of AU$88.03 offers roughly 17% upside, and the company delivers a solid 4% dividend yield with a 62% payout ratio backed by strong free cash flow. Fundamentals are robust: revenue grew 7.3% YoY, ROE stands at 29%, and operating margins are healthy, while the balance sheet shows manageable debt (debt‑to‑equity ~43%). Recent half‑year results sparked a market rally to AU$89.10, highlighting investor optimism.
Overall, JB Hi‑Fi appears undervalued relative to its intrinsic value, benefits from a sustainable dividend, and possesses a resilient business model, though short‑term technical indicators remain bearish and volatility is elevated.
Overall, JB Hi‑Fi appears undervalued relative to its intrinsic value, benefits from a sustainable dividend, and possesses a resilient business model, though short‑term technical indicators remain bearish and volatility is elevated.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and elevated volatility
- Attractive dividend yield and cash flow
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF upside of ~17% to fair value
- Consistent earnings growth and strong ROE
- Sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Durable retail and services franchise across Australia and NZ
- High return on equity and solid free cash flow generation
- Undervalued valuation metrics relative to intrinsic worth
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin4.40%
P/E Ratio17.9
ROE29.24%
ROA10.69%
Debt/Equity43.39
P/B Ratio5.1
Op. Cash FlowA$665.1M
Free Cash FlowA$519.5M
Technical Analysis
TrendBearish
RSI41.0
SupportA$72.26
ResistanceA$90.13
MA 20A$81.54
MA 50A$85.23
MA 200A$102.65
MACDBearish
VolumeDecreasing
Fear & Greed Index76.3
Valuation
Fair ValueA$88.03
Target PriceA$92.64
Upside/Downside17.70%
GradeUndervalued
TypeBlend
Dividend Yield4.00%
Risk Assessment
Beta0.45
Volatility41.74%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.